A Study in Patients With Myasthenia Gravis in China
← catalyst calendarNCT06700616 · readout in 498 d
Sponsored by AstraZeneca (industry) · AZN — their whole pipeline →.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
1,199actual
Sites
20
Country
China
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-09-26 | actual | When the study began enrolling |
| Primary completion | 2027-12-30 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-12-30 | estimated | The whole study's end, after follow-up |
| First posted | 2024-11-22 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-11 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Myasthenia Gravis
Primary outcomes
what the primary-completion date above is the date OFClinical outcome
measured Every 6 months up to 3 years
Treatment method
measured Every 6 months up to 3 years
Patient-reported outcome
measured Every 6 months up to 3 years
Clinical outcome
measured Every 6 months up to 3 years
Clinical outcome
measured Every 6 months up to 3 years
Clinical outcome
measured Every 6 months up to 3 years
Clinical outcome
measured Every 6 months up to 3 years
Patient-reported outcome
measured Every 6 months up to 3 years
Patient-reported outcome
measured Every 6 months up to 3 years
Treatment duration
measured Every 6 months up to 3 years
Treatment dose
measured Every 6 months up to 3 years
Treatment frequency
measured Every 6 months up to 3 years
Permalink · AZN's whole pipeline · Catalyst calendar · Every registered study · What changed